Evidence map›Paper›PMID 37159543›Full record

ArticleGM crops & food2023

Empirical analysis on the impact of trust in government, purposes of GM crops, and farmers' expectations on the delayed commercialization of GM crops in China---Based on Xinjiang and Guangdong survey samples.

Yu Pang

Abstract read
In one paragraph

Article in GM crops & food, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The Fusion GenePlants (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yu PangDepartment of Management of Bioeconomy, Innovation & Governance, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.ORCID 0009-0005-2024-1500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GM crops, as a widely researched and applied biotechnology, hold significant strategic and practical implications for promoting the commercialization of GM crops in China, driving agricultural industry upgrading, and fostering economic and social development. However, despite their potential benefits, the commercialization of GM crops in China has been consistently delayed. Therefore, this study aims to explore the trust relationship between the government and the public in the field of genetically modified organisms and the heterogeneous impacts generated at the production and consumption ends. We primarily focus on insect-resistant cotton and genetically modified papaya as representatives and base our research on survey data from Xinjiang and Guangdong. By employing factor analysis and establishing multiple Probit models with government trust, crop purposes, and farmer expectations as independent variables, and the commercialization of GM crops as the dependent variable, we conduct two sets of empirical analyses. The study finds that government trust has a more significant impact on consumer concerns about whether to consume GM products than on producers, who prioritize farmers' desire for agricultural product profitability. Age and education levels also influence the public's acceptance of planting GM crops, but the effects are not as significant as the core variables mentioned earlier. Based on this, we conclude that consumers and farmers have different positions and contradictions in the specific scenario of delayed GM commercialization in China. In this context, this paper argues that diversified strategies should be adopted to address the issue of commercialization of GM crops in China.

Indexed as

FarmersTrustChinaCrops, AgriculturalGovernmentHumansMotivationChinaDelayed commercialization of GM cropsFarmers’ expectationsGovernment trustPurposes of GM crops

Identifiers

PMID37159543
PMCPMC10171116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.